DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

$25.88
-0.29 (-1.11%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 18 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target +278.1% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $25.88
Current
$25.88
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
196.2%
Low target
Base Case
$97.86
+278.1%
Avg target
Bull Case
$132.93
+413.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$26.26
-1.4% from high
52-Week Low
$9.32
+177.7% from low
50-Day SMA
$18.16
+42.5% vs SMA
200-Day SMA
$14.91
+73.6% vs SMA
RSI (14)
28.7
Oversold
Target vs 52W High
$97.86
+272.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +5.4%
AMGN
Amgen Inc
Hold 43 49% $190.87 -52.7%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +179.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -42.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -46.0%
BIIB
Biogen Inc
Buy 44 64% $91.45 -55.7%